2-(Chloromethyl)-4-Methylquinazoline
- Grade: Pharmaceutical Intermediate
- Origin: India
- Application: Linagliptin API synthesis

Consistent quality, commercial-scale supply and complete technical documentation for pharmaceutical customers and partners worldwide.
Three pharmaceutical intermediates offered for technical evaluation, qualification and commercial supply.
Kimika GMPsol Pvt. Ltd. focuses on technological project management, complex products, GMP consultancy and support for regulated markets. The wider Pharma-in-Future group traces its foundation to 2004; Kimika GMPsol Pvt. Ltd. is incorporated in India as a private limited company.
Our product-focused approach combines pharmaceutical manufacturing and sourcing support with technical, quality and regulatory experience.
Documentation can be provided to support technical assessment and procurement qualification.
Our supply proposition is built around dependable quality, responsive technical communication and support from evaluation through commercial supply.
Request a COA, technical package, sample or commercial quotation from our team.
M/s. Kimika GMPsol Pvt. Ltd.
Factory: E-128, M.I.D.C., Tarapur Industrial Area, Boisar, Dist. Palghar, Maharashtra, India – 401 506.
Office: A-304, Alpine, Timber Green Park, Western Express Highway, Dahisar (E), Mumbai – 400 068, India.
Phone: +91 22 2897 2882 / +91 22 2896 6920
Email: abghogare@pharmainfuture.com